4.6 Review

Modelling the Interplay Between Neuron-Glia Cell Dysfunction and Glial Therapy in Autism Spectrum Disorder

Journal

CURRENT NEUROPHARMACOLOGY
Volume 21, Issue 3, Pages 547-559

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1570159X21666221221142743

Keywords

Autism spectrum disorder (ASD); neuron-glial interaction; glial cell dysfunction; microglial activation; glial \ntherapy

Ask authors/readers for more resources

Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder characterized by underdeveloped brain and impaired social interaction. Recent research suggests that disturbances in neuron-glia interactions play a significant role in the pathophysiology of ASD. Glial cells, in addition to neurons, are essential for mental activities, and a new strategy emphasizing neuron-glia interactions should be applied. Dysfunctional neuron-glia connections result in abnormal neural network formation and neurotransmission, leading to the malfunctioning of brain circuits and behavioral issues. Reactive glial cells and dysfunction in microglia have been associated with autism, and various approaches involving glial cell treatment are being explored.
Autism spectrum disorder (ASD) is a complicated, interpersonally defined, static condition of the underdeveloped brain. Although the aetiology of autism remains unclear, disturbance of neuron-glia interactions has lately been proposed as a significant event in the pathophysiology of ASD. In recent years, the contribution of glial cells to autism has been overlooked. In addition to neurons, glial cells play an essential role in mental activities, and a new strategy that emphasises neuron-glia interactions should be applied. Disturbance of neuron-glia connections has lately been proposed as a significant event in the pathophysiology of ASD because aberrant neuronal network formation and dysfunctional neurotransmission are fundamental to the pathology of the condition. In ASD, neuron and glial cell number changes cause brain circuits to malfunction and impact behaviour. A study revealed that reactive glial cells result in the loss of synaptic functioning and induce autism under inflammatory conditions. Recent discoveries also suggest that dysfunction or changes in the ability of microglia to carry out physiological and defensive functions (such as failure in synaptic elimination or aberrant microglial activation) may be crucial for developing brain diseases, especially autism. The cerebellum, white matter, and cortical regions of autistic patients showed significant microglial activation. Reactive glial cells result in the loss of synaptic functioning and induce autism under inflammatory conditions. Replacement of defective glial cells (Cell-replacement treatment), glial progenitor cell-based therapy, and medication therapy (inhibition of microglia activation) are all utilised to treat glial dysfunction. This review discusses the role of glial cells in ASD and the various potential approaches to treating glial cell dysfunction.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available